The cost of injecting healthy people, “especially children,” with a Pfizer or Moderna COVID-19 vaccine “outweighs any claimed though unvalidated benefits,” according to researchers who analyzed adverse events data from more than 10 regulatory surveillance and self-reporting systems during the first two years of the COVID-19 vaccine rollout.
“Our meta-analysis of both national and international vaccine adverse events emphasizes the importance of re-evaluating public health policies that promote universal mass injection and multiple boosters for all demographic groups,” said the authors of a peer-reviewed study published this month in the International Journal of Vaccine Theory, Practice, and Research.
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr